Profound Medical Corp.
TSX:PRN.TO · Toronto Stock Exchange
+$0.11 today
Vol 0.00M · Avg 0.01M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-65.3%
avg -73.8%
ROIC
-31.1%
avg -51.0%
ROA
-30.8%
avg -51.1%
Analysis
ROA is currently the strongest return metric at -30.8% versus its period average of -51.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Arun Swarup Menawat | Chairman of the Board & Chief Executive Officer | $1.39M | — | 71 | — | — |
Mathieu Burtnyk | President | $670,087.00 | — | 44 | — | — |
Rashed Dewan | Chief Financial Officer | $659,524.00 | — | 58 | — | — |
Thomas Tamberrino | Chief Commercial Officer | $533,739.00 | — | 46 | — | — |
Levant Tinaz | Software Developer | — | — | — | — | — |
Stephen Kilmer | Investor Relations | — | — | — | — | — |
Matthew Sobczyk | Assistant Corporate Controller | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
NervGen Pharma Corp.
NGEN.V
$407.94M
Eupraxia Pharmaceuticals Inc.
TSX:EPRX.TO
$325.95M
Medical Facilities Corporation
TSX:DR.TO
$315.55M
Auxly Cannabis Group Inc.
TSX:XLY.TO
$250.54M
Quipt Home Medical Corp.
QIPT.TO
$221.44M
CareRx Corporation
TSX:CRRX.TO
$203.03M
Cybin Inc.
CYBN.NE
$154.92M
HLS Therapeutics Inc.
TSX:HLS.TO
$133.86M
Jushi Holdings Inc.
JUSH.CN
$133.80M
VentriPoint Diagnostics Ltd.
VPT.V
$22.52M
Who manages PRN.TO?
Profound Medical Corp. (PRN.TO) lists 7 active executives. The top listed executive is Mathieu Burtnyk, President.
Explore More
Continue the stock analysis
Jump to another research area for this company.